Cargando…
Results of the Ticlid or Plavix Post-Stents (TOPPS) trial: do they justify the switch from ticlopidine to clopidogrel after coronary stent placement?
In the Ticlid or Plavix Post-Stents (TOPPS) trial, 1016 patients undergoing successful coronary stent placement were randomized to receive aspirin and either ticlopidine or clopidogrel. In this trial, the dosages and regimens of ticlopidine and clopidogrel resembled more closely those used in most c...
Autor principal: | Berger, Peter B |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59605/ https://www.ncbi.nlm.nih.gov/pubmed/11714416 http://dx.doi.org/10.1186/cvm-1-2-083 |
Ejemplares similares
-
Comparison of Clopidogrel and Ticlopidine/Ginkgo Biloba in Patients With Clopidogrel Resistance and Carotid Stenting
por: Chung, Jong-Won, et al.
Publicado: (2019) -
A better effect of cilostazol for reducing in-stent restenosis after femoropopliteal artery stent placement in comparison with ticlopidine
por: Ikushima, Ichiro, et al.
Publicado: (2011) -
Perioperative clopidogrel (Plavix) continuation in shoulder arthroplasty: approach cautiously
por: Rogers, Thomas H., et al.
Publicado: (2022) -
Stent placement in patients with acute subarachnoid haemorrhage: when is it justified?
por: Murchison, Andrew G., et al.
Publicado: (2018) -
Plavix fzzranchise in jeopardy
Publicado: (2006)